SAN DIEGO–(BUSINESS WIRE)–Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
Author: Business Wire
Vivior Is Rolling out Its Visual Behavior Monitor in the United States
ZURICH–(BUSINESS WIRE)–Vivior offers an innovative service for all customers and patients that require a solution to improve their vision. Their objective behavioral data supports experts like ophthalmic surgeons, optometrists, opticians and others t…
IVERIC bio, Inc. Announces Closing of Public Offering and Concurrent Private Placement with $160 Million in Gross Proceeds
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. announced the closing of public offering and concurrent private placement with $160 million in gross proceeds.
Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in Metastatic Uveal Melanoma
BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced results from a study that provi…
Assessment of COVID-19's Effect on Ophthalmology Therapeutics Market 2020-2024 | Increase in Prevalence of Eye Diseases to Augment Growth | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmologyTherapeuticsMarket–The Global Ophthalmology Therapeutics Market will grow by USD 10.42 bn during 2020-2024
Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announc…
Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Premarket Approval (PMA) application for ReActiv8®, its implantable neurost…
COVID-19 Impact and Recovery Analysis- Eyewear Market 2020-2024 | Increasing Prevalence Of Vision Disorder to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #EyewearMarket–The Global Eyewear Market will grow by $ 57.69 bn during 2020-2024
OneLegacy Expands Outreach to Diverse Communities Through Social Media Programs, Virtual Townhall Series and Panels, as Well as Inspirational Stories of Donation and Transplantation
LOS ANGELES–(BUSINESS WIRE)–OneLegacy has expanded its programs serving communities of color, aimed at addressing the disparities that currently exist in organ donation.
Lineage Cell Therapeutics Reinitiates Patient Enrollment in Clinical Study of OpRegen® for the Treatment of Dry AMD With Geographic Atrophy
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage cell therapy company which manufactures and transplants specific cell types to treat diseases and serious medical conditi…
IVERIC bio, Inc. Announces Proposed Offering of Common Stock and Pre-Funded Warrants and Concurrent Private Placement
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced that it is commencing an underwritten public offering of $50.0 million of shares of its common stock.
IVERIC bio, Inc. Announces Proposed Offering of Common Stock and Pre-Funded Warrants and Concurrent Private Placement
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced that it is commencing an underwritten public offering of $50.0 million of shares of its common stock.
2020 On-site Launches First Direct-to-Patient Clinical Trial Support
BOSTON–(BUSINESS WIRE)–In response to the impact of COVID-19 on clinical trials, 2020 On-site has expanded its signature convenience-based eye care service to include a unique solution for trial Sponsors, Investigators, Sites, and Patients. The compa…
Loganville Walmart Supercenter Remodel Features Opening of New Walmart Health
LOGANVILLE, Ga.–(BUSINESS WIRE)–Families in the Loganville area can now experience a remodeled Walmart Supercenter that’s offering customers new ways to save money, while living better – and healthier – lives, through the opening of the new Walmart H…
Insights on the Worldwide Tonometer Market to 2025 – Major Players and Strategy Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Tonometer Market – Forecasts from 2020 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global tonometer market is projected to grow at a CAGR of 3.22% from a market size of USD293.010 millio…
Lineage Cell Therapeutics to Present Tomorrow at 2020 Raymond James Human Health Innovation Conference
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced that Brian M. Culley, Chief Exec…
4D Molecular Therapeutics Raises $75 Million in Series C Financing
EMERYVILLE, Calif.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, announced the closing of its $75 million Series C financing. The round…
Burden of COVID-19 on the Market & Rehabilitation Plan | Global Eyeglasses Market 2020-2024 | High Prevalence of Vision Disorders to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #EyeglassesMarket–The Global Eyeglasses Market will grow by $41.98 bn during 2020-2024
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Ocular Therapeutix™ to Present Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…